Hypertension Clinical Trials

Showing 2981-3000 of 3,037 trials

Candesartan and Candesartan/ Hydrochlorothiazide in the Treatment of Patients With Hypertension and LVH

NCT00607633

The CandLE study with at maximum daily dose of 32 mg candesartan or 16/12.5 mg candesartan/hydrochlorothiazide has the objective to evaluate under naturalistic conditions, i.e. under routine medical care conditions, the impact of the antihypertensive therapy with candesartan or candesartan/HCT on relevant medical parameters related to the left ventricular hypertrophy (LVH) as well as the efficacy and tolerability of candesartan or candesartan/HCT in subjects suffering from essential hypertension..

Essential HypertensionLeft Ventricular Hypertrophy

AstraZeneca686 participantsStarted Jan 2007

COMPLETEDNA

Adherence to Weight Loss for Hypertension in African American Women

NCT00142649

To develop a culturally tailored intervention intended to promote adherence to nutrition and physical activity regimens designed to result in weight loss for African American women.

Cardiovascular DiseasesHeart DiseasesHypertension+1 more

National Heart, Lung, and Blood Institute (NHLBI)Started Sep 2002

COMPLETEDPhase 2

Efficacy and Safety of Simvastatin in the Treatment of Portal Hypertension

NCT00594191

The purpose of this study is to evaluate the effects of continuous simvastatin administration on the hepatic venous pressure gradient (HVPG), as a surrogate marker of prognosis, and its safety in patients with cirrhosis and portal hypertension.

CirrhosisPortal Hypertension

Hospital Clinic of Barcelona59 participantsStarted Mar 2004

Barcelona, Barcelona, Spain • Madrid, Madrid, Spain • Madrid, Madrid, Spain

COMPLETEDPhase 4

Brimonidine 0.1% Versus Brinzolamide 1% as Adjunctive Therapy to Latanoprost 0.005%

NCT00440141

Patients with glaucoma or ocular hypertension currently being treated with latanoprost 0.005%, and in need of additional IOP lowering will be randomized to receive either brimonidine 0.1% or brinzolamide 1% three-times daily as adjunctive therapy to latanoprost 0.005%

GlaucomaOcular Hypertension

Allergan40 participantsStarted Jul 2006

Atlanta, Georgia, United States

Candesartan and Candesartan/ Hydrochlorothiazide in the Treatment of Patients With Hypertension and LVH

Adherence to Weight Loss for Hypertension in African American Women

Efficacy and Safety of Simvastatin in the Treatment of Portal Hypertension

Brimonidine 0.1% Versus Brinzolamide 1% as Adjunctive Therapy to Latanoprost 0.005%

Related Searches

Cognitive/Cerebrovascular Consequences of HTN Treatment

Effects of Antihypertensive Treatment in HIV Infected Patients: Candesartan Versus Lercanidipine

Remifentanil for General Anesthesia in Preeclamptics

Effects of Lumiracoxib and Ibuprofen on Blood Pressure and Urinary Eicosanoid Excretion in Osteoarthritis Patients With Controlled Hypertension

Collection of Blood and Urine Specimens From Volunteers Utilizing Health Examination Services

Is Orthostatic Hypotension Associated With Nondipping Hypertension

Transitioning To IV Remodulin From Ventavis in Patients With PAH: Safety, Efficacy and Treatment Satisfaction

Safety and Efficacy Study of Sitaxentan Sodium (Thelin™) in Patients With Pulmonary Arterial Hypertension

Phase IIa Safety and Efficacy Study of SPP635 in Mild to Moderate Hypertension

Irbesartan Effects on Endothelial Dysfunction in Hypertensive Type II Diabetic Patients Comparing Atenolol

Recognition of Abnormal Pediatric Blood Pressures in Primary Care

Simvatstatin Used to Treat Pulmonary Hypertension

Losartan Therapy in Pulmonary Hypertension

The Effect of Daily Intakes of Dairy Products on Blood Pressure in Human Beings

Lifestyle Intervention in Primary Health Care - the Björknäs Study

Haemodialysis Salt Reduction Study